Humana Reconfirms Bad News On Utilization In MA
After an earlier filing, Humana reconfirmed bad news on the medical expense front. Because it is a predominant Medicare Advantage (MA) insurer, it has seen a major and unexpected rise in utilization, which impacted the company’s 2023 numbers and prospects for 2024 and beyond. Broussard is one of the smartest healthcare leaders out there and he is someone I listen to closely. Given the medical expense rise, rate compression, and regulatory changes (such as the new prior authorization rule), Broussard said he expects similar pricing adjustments from other payers, as the spike in utilization along with ongoing regulatory changes will have major impacts in 2025 and potentially beyond. Broussard says this could very well be industrywide. Humana reduced benefits for 2024 and this could be a continued trend into the future. Humana plans on cutting about $700 million in administrative costs.
It doesn’t mean MA is not a good place to be, but it does show the shortsightedness of the Centers for Medicare and Medicaid Services (CMS) and Capitol Hill as they seek to bind the hands of MA plans too much.
Additional articles: https://www.modernhealthcare.com/finance/humana-cuts-medicare-advantage-changes-earnings and https://www.healthcaredive.com/news/humana-dour-2024-profit-forecast/705537/
(Some articles may require a subscription.)
#medicareadvantage #humana #medicalexpense
